As a new generation of paclitaxel preparations, albumin-bound paclitaxel (albumin-paclitaxel) is a first-line drug for triple-negative breast cancer chemotherapy and occupies an extremely important position in the chemotherapy of breast cancer and other malignant tumors. Here, ALB is linked to breast cancer.